The relationship between sarcopenia and metabolic parameters of ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography (¹⁸F-FDG PET/CT) and the prognostic value of sarcopenia in early-stage non-small cell lung cancer.

ABSTRACT:

Background

Patients with lung cancer face a heightened risk of developing sarcopenia. Despite this known risk, the impact of sarcopenia on the long-term prognosis of lung cancer patients, specifically concerning progression-free survival (PFS) and overall survival (OS), remains unclear. The primary objective of our study was to examine the correlation between metabolic parameters derived from ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography (¹⁸F-FDG PET/CT) and sarcopenia, as well as the prognostic value of sarcopenia in patients with surgically resected early-stage non-small cell lung cancer (NSCLC).

Methods

In this retrospective cross-sectional study, we analyzed 187 NSCLC patients who underwent ¹⁸F-FDG PET/CT at the

SUBMITTER: Xu X 

PROVIDER: S-EPMC11485386 | biostudies-literature | 2024 Oct

REPOSITORIES: biostudies-literature